Your browser doesn't support javascript.
loading
The association between genetically elevated polyunsaturated fatty acids and risk of cancer.
Haycock, Philip C; Borges, Maria Carolina; Burrows, Kimberley; Lemaitre, Rozenn N; Burgess, Stephen; Khankari, Nikhil K; Tsilidis, Konstantinos K; Gaunt, Tom R; Hemani, Gibran; Zheng, Jie; Truong, Therese; Birmann, Brenda M; OMara, Tracy; Spurdle, Amanda B; Iles, Mark M; Law, Matthew H; Slager, Susan L; Saberi Hosnijeh, Fatemeh; Mariosa, Daniela; Cotterchio, Michelle; Cerhan, James R; Peters, Ulrike; Enroth, Stefan; Gharahkhani, Puya; Le Marchand, Loic; Williams, Ann C; Block, Robert C; Amos, Christopher I; Hung, Rayjean J; Zheng, Wei; Gunter, Marc J; Smith, George Davey; Relton, Caroline; Martin, Richard M.
Afiliación
  • Haycock PC; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom. Electronic address: philip.haycock@bristol.ac.uk.
  • Borges MC; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Burrows K; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Lemaitre RN; Department of Medicine, Cardiovascular Health Research Unit, University of Washington, Seattle, WA, USA.
  • Burgess S; MRC Biostatistics Unit, University of Cambridge, USA.
  • Khankari NK; Division of Genetic Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Tsilidis KK; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Gaunt TR; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Hemani G; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Zheng J; Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Di
  • Truong T; Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, Team "Exposome, Heredity, Cancer and Health", CESP, Villejuif, France.
  • Birmann BM; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • OMara T; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, Faculty of Health Sciences, University of Queensland, Australia.
  • Spurdle AB; Genetics and Computational Biology Division, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia; School of Medicine, Faculty of Health Sciences, University of Queensland, Australia.
  • Iles MM; Leeds Institute for Data Analytics, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Law MH; Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Australia; School of Biomedical Sciences, Faculty of Health, and Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
  • Slager SL; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Saberi Hosnijeh F; Institute for Risk Assessment Sciences, Utrecht University, Netherlands.
  • Mariosa D; Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.
  • Cotterchio M; Dalla Lana School of Public Health, University of Toronto, Canada; Prevention and Cancer Control, Cancer Care Ontario, Ontario Health, Toronto, ON, Canada.
  • Cerhan JR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
  • Peters U; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, USA; Department of Epidemiology, School of Public Health, University of Washington, Seattle, USA.
  • Enroth S; Department of Immunology, Genetics, and Pathology, Biomedical Center, Science for Life Laboratory (SciLifeLab) Uppsala, Uppsala University, Uppsala, Sweden.
  • Gharahkhani P; Statistical Genetics Lab, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston QLD, 4006, Australia.
  • Le Marchand L; University of Hawaii Cancer Center, Honolulu, HI, USA.
  • Williams AC; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
  • Block RC; Department of Public Health Sciences, University of Rochester, NY, USA.
  • Amos CI; Dan L Duncan Comprehensive Cancer Center Baylor College of Medicine, USA.
  • Hung RJ; Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital and University of Toronto, Canada.
  • Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Gunter MJ; Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC), 150 Cours Albert Thomas, Lyon, France.
  • Smith GD; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Relton C; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom.
  • Martin RM; MRC Integrative Epidemiology Unit (IEU), Population Health Sciences, University of Bristol, Bristol, United Kingdom; The National Institute for Health Research (NIHR) Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol,
EBioMedicine ; 91: 104510, 2023 May.
Article en En | MEDLINE | ID: mdl-37086649

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Neoplasias Colorrectales / Enfermedades Inflamatorias del Intestino / Ácidos Grasos Omega-3 / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Neoplasias Colorrectales / Enfermedades Inflamatorias del Intestino / Ácidos Grasos Omega-3 / Carcinoma de Células Escamosas de Esófago Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2023 Tipo del documento: Article Pais de publicación: Países Bajos